Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014190 220008711 null 6.6 Curative (C) 2016-05-14 2016-05-15 AML Int Guide ADE 8+3+5 (2) 02 N 220032781 ADE
220014191 220008714 1.82 60 Curative (C) 2013-03-31 2013-04-09 Idarubicin+Tretinoin Spanish Crse2 N N 220032789 IDARUBICIN + TRETINOIN
220014192 220008716 1.66 6.9 Curative (C) 2013-06-19 2013-07-28 CYCLOPHOSPHAMIDE + FLUDARABINE null null 220032789 CYCLOPHOSPHAMIDE + FLUDARABINE
220014193 220008717 null null Curative (C) 2015-07-22 2015-07-22 ADE 8+3+5 02 N 220032790 ADE
220014197 220021910 null 0 Curative (C) 2017-01-16 2017-01-16 FLAG null N 220032803 FLAG
220014198 220022106 null 0 Disease modification (D) null 2015-09-29 BOSUTINIB null null 220032803 BOSUTINIB
220014199 220022307 1.98 39.7 Curative (C) 2017-02-09 2017-02-09 RUXOLITINIB N N 220032807 RUXOLITINIB
220014200 220014691 1.63 74.2 Curative (C) null 2017-12-05 Triple / Double Intrathecal Therapy N null 220032814 TRIPLE INTRATHECAL
220014201 220008723 1.8 82.9 Curative (C) 2014-01-05 2014-01-10 FLAG 2 N 220032820 FLAG
220014202 220014692 1.75 100.3 Curative (C) 2014-03-14 2014-10-03 IDARUBICIN + TRETINOIN Y N 220032828 IDARUBICIN + TRETINOIN
220014203 220014692 null 62.95 Disease modification (D) 2013-11-02 2013-11-02 ATG + Busulfan + Fludarabine N null 220032828 ATG + BUSULFAN + FLUDARABINE
220014204 220008724 1.88 13.1 Curative (C) 2013-10-23 2013-10-23 AML Int Guide ADE 8+3+5 (2) N null 220032836 ADE
220014205 220008725 1.83 70 Curative (C) null 2018-03-25 ATG + Busulfan + Fludarabine N N 220032838 ATG + BUSULFAN + FLUDARABINE
220014206 220008725 0 null Curative (C) 2015-08-28 2015-08-28 IDARUBICIN + TRETINOIN N N 220032838 IDARUBICIN + TRETINOIN
220014207 220008725 1.75 57.7 Curative (C) 2015-09-20 2015-09-20 Cyclophosphamide+Fludara+TBI Allo null N 220032838 CYCLOPHOSPHAMIDE + FLUDARABINE
220014208 220008725 1.72 113.8 Curative (C) 2013-02-14 2013-02-14 AML16 Low Dose Cytarabine N N 220032838 AML16 TRIAL
220014209 220008726 1.73 78.3 Curative (C) null 2013-03-29 ATG + Busulfan + Fludarabine N N 220032855 ATG + BUSULFAN + FLUDARABINE
220014210 220008728 1.5 90 Curative (C) 2015-04-11 2015-06-06 BOSUTINIB 02 Y 220032856 BOSUTINIB
220014211 220008733 null null Curative (C) 2016-06-04 2016-06-04 IDARUBICIN + TRETINOIN N N 220032862 IDARUBICIN + TRETINOIN
220014212 220008734 1.65 55 Curative (C) 2017-01-12 2017-01-15 RUXOLITINIB 02 N 220032862 RUXOLITINIB
220014213 220008737 1.75 83.8 Curative (C) 2015-11-03 2015-11-03 Methotrexate intrathecal N N 220032865 METHOTREXATE INTRATHECAL
220014214 220008738 1.6 56.7 Curative (C) 2015-09-16 2015-12-21 BOSUTINIB N N 220032865 BOSUTINIB
220014215 220014698 null null Curative (C) 2017-05-25 2017-05-25 AML16 Low Dose Cytarabine N N 220032871 AML16 TRIAL
220014216 220008740 1.66 75 Curative (C) 2018-02-02 2018-02-05 BOSUTINIB N N 220032871 BOSUTINIB
220014217 220008744 1.17 79.3 Curative (C) 2014-10-06 2014-11-18 BOSUTINIB Y null 220032874 BOSUTINIB
220014218 220014700 1.65 null Curative (C) 2014-09-17 2014-09-17 Cyclophosphamide+Fludara+TBI Allo N null 220032874 CYCLOPHOSPHAMIDE + FLUDARABINE
220014219 220014700 1.65 55.95 Curative (C) 2018-03-31 2018-04-01 CYCLOPHOSPHAMIDE + FLUDARABINE 02 N 220032874 CYCLOPHOSPHAMIDE + FLUDARABINE
220014220 220014701 0 71 Curative (C) 2015-03-17 2015-03-25 AML16 DA 3+8 2 N 220032881 AML16 TRIAL
220014221 220019892 1.58 60.3 Curative (C) 2017-05-27 2017-05-27 FLAG N N 220032886 FLAG
220014222 220008747 1.76 72.5 Curative (C) 2013-01-29 2013-02-02 Cyclophosphamide TBI Allograft N N 220032887 CYCLOPHOSPHAMIDE
220014223 220008748 1.77 17.5 null null 2016-12-11 Triple Intrathecal N N 220032887 TRIPLE INTRATHECAL
220014224 220018031 1.59 5.8 Curative (C) 2017-09-03 2017-09-09 FLAG 2 N 220032899 FLAG
220014225 220008750 1.51 53.1 Curative (C) 2016-02-15 2016-12-06 FLAG N N 220032900 FLAG
220014226 220008751 1.85 12.4 Curative (C) 2017-10-23 2017-10-26 Cyclophosphamide+Fludara+TBI Allo N N 220032905 CYCLOPHOSPHAMIDE + FLUDARABINE
220014227 220008752 null null Curative (C) 2017-12-19 2017-12-20 Idarubicin+Tretinoin Spanish Crse2 02 N 220032908 IDARUBICIN + TRETINOIN
220014228 220008755 1.55 null Curative (C) 2015-08-08 2015-09-21 ATG + Busulfan + Fludarabine 02 null 220032911 ATG + BUSULFAN + FLUDARABINE
220014229 220008759 1.7 119 Curative (C) null 2017-10-18 RUXOLITINIB N N 220032917 RUXOLITINIB
220014230 220008760 1.73 94.25 Curative (C) 2014-02-17 2014-10-02 RUXOLITINIB N N 220032919 RUXOLITINIB
220014231 220008762 null 83.2 Curative (C) 2015-07-26 2015-07-26 ATG + Busulfan + Fludarabine 2 N 220032920 ATG + BUSULFAN + FLUDARABINE
220014232 220008764 1.67 133.5 null 2013-11-01 2013-11-01 Cyclophosphamide TBI Allograft null null 220032927 CYCLOPHOSPHAMIDE
220014233 220014706 null 60 Curative (C) 2017-04-14 2017-04-14 IDARUBICIN + TRETINOIN N null 220032932 IDARUBICIN + TRETINOIN
220014234 220008766 1.63 16.2 Curative (C) 2018-01-09 2018-02-11 BOSUTINIB 02 N 220032935 BOSUTINIB
220014235 220014708 1.51 55 Curative (C) 2015-10-08 2015-10-09 FLAG 02 N 220032935 FLAG
220014236 220018034 1.8 88.8 Curative (C) 2016-10-05 2016-10-05 Idarubicin+Tretinoin Spanish Crse4 N N 220032948 IDARUBICIN + TRETINOIN
220014237 220018034 1.81 84.5 Curative (C) 2016-03-20 2016-03-20 FLAG 02 Y 220032948 FLAG
220014238 220021572 1.67 46 Curative (C) 2017-07-23 2017-07-28 FLAG 02 N 220032956 FLAG
220014239 220008768 1.74 110 Curative (C) 2016-05-23 2016-05-24 Methotrexate intrathecal 2 N 220032973 METHOTREXATE INTRATHECAL
220014240 220008771 1.68 null Palliative (P) 2016-07-28 2017-04-12 AML16 DA 3+8 N N 220032980 AML16 TRIAL
220014241 220008774 1.7 60 Curative (C) 2013-10-18 2013-10-22 CYCLOPHOSPHAMIDE + FLUDARABINE 2 Y 220032982 CYCLOPHOSPHAMIDE + FLUDARABINE
220014242 220014712 0 7.1 Curative (C) 2016-05-26 2016-05-26 Idarubicin+Tretinoin Spanish Crse2 N N 220032988 IDARUBICIN + TRETINOIN